The increasing number of elderly patients with complex
|
|
- Lynette Blair
- 5 years ago
- Views:
Transcription
1 Valved Stentless Composite Graft: Clinical Outcomes and Hemodynamic Characteristics Paul P. Urbanski, MD, Anno Diegeler, MD, Alexander Siebel, MD, Michael Zacher, MD, and Robert W. Hacker, MD Herz- und Gefaess-Klinik, Bad Neustadt, Germany Background. The valved stentless composite graft has become well established in our hospital for replacement of the ascending aorta and aortic valve in elderly patients and those with contraindication for lifelong anticoagulation. This study was conducted to evaluate the postoperative hemodynamic characteristics and clinical outcomes after implantation of this device. Methods. Between November 1998 and February 2001, 45 consecutive patients with a mean age of 69 years underwent implantation of a composite graft using a stentless valve prosthesis (Toronto SPV) incorporated in a collagen-coated Dacron tube (InterGard). The indication for surgery was aortic valve disease with an accompanying true aneurysm of the ascending aorta in 42 patients and a dissection of the aortic wall in 3 patients. Postoperative echocardiographic examinations were performed before discharge from the hospital and at the time of the follow-up. Mean follow-up duration was 18 months (range 3 to 30 months). Results. There was no perioperative mortality. During follow-up, there were two noncardiac, nonvalve-related deaths. Echocardiographic evaluation before discharge and at follow-up demonstrated favorable hemodynamics of the valve prosthesis with mean transvalvular gradients of mmhg and mmhg, respectively. No regurgitation across the valve and no contact of the cusps with the Dacron tube were seen in any case. Conclusions. A stentless composite graft for replacement of the aortic valve and ascending aorta offers excellent hemodynamic results and is a suitable device for patients in whom anticoagulation should be avoided. (Ann Thorac Surg 2003;75:467 71) 2003 by The Society of Thoracic Surgeons The increasing number of elderly patients with complex diseases of the aortic valve and the ascending aorta stimulates the search for an ideal biological transplant [1, 2]. Homologous transplants are well suited for the replacement of the ascending aorta but their availability is limited. Biological conduits with a stented valve prosthesis on the other hand are rarely used because of the concern that eventual structural valve deterioration would require complete conduit replacement in a technically demanding operation [3, 4]. With the introduction of stentless biological valve prostheses, another alternative has emerged. These devices are readily available in various sizes without limitations and, in the case of structural valve deterioration requiring reoperation, only the cusps need to be replaced [5 7]. In addition, improved fixation techniques of the biological material encourages the expectation of prolonged durability [8, 9]. In 1998, we introduced a procedure to assemble, intraoperatively, a composite graft consisting of a stentless valve prosthesis incorporated in a sealed woven Dacron (InterVascular, La Ciotat, France) tube [10, 11]. The resulting device has since become well established in our hospital and is routinely used for replacement of the Accepted for publication Aug 21, Address reprint requests to Dr Urbanski, Herz- und Gefaess-Klinik, Salzburger Leite 1, Bad Neustadt, Germany; urbanski@kardiochirurg.de. aortic valve and ascending aorta in patients in whom anticoagulation should be avoided. In this study, the postoperative hemodynamic characteristics and midterm clinical results after implantation of this valved composite graft are evaluated. Patients and Methods Between November 1998 and February 2001, 45 consecutive patients, in whom anticoagulation was not desirable or contraindicated, underwent implantation of a stentless valved composite graft for replacement of the aortic valve and the ascending aorta. All operations were performed by the same surgeon (P.P.U.) The group included 25 men and 20 women with a mean age of 69.0 years (range, 24 to 79 years). A 24-year-old female patient with Turner s syndrome was the exceptional case among the otherwise elderly group. Preoperative patients characteristics are shown in Table 1. Forty-two patients had a true aneurysm of the ascending aorta with a mean diameter of 5.8 cm. In 3 patients, dissection of the aortic wall was the indication for surgery. Three patients had previous cardiac surgery. All patients underwent preoperative cardiac catheterization and echocardiographic examination. To further verify the pathology of the ascending aorta or the aortic arch, computed tomography or magnetic resonance imaging was performed in 26 patients. Table 2 shows the pathology of the aortic valve and the aortic wall by The Society of Thoracic Surgeons /03/$30.00 Published by Elsevier Science Inc PII S (02)
2 468 URBANSKI ET AL Ann Thorac Surg VALVED STENTLESS COMPOSITE GRAFT 2003;75: Table 1. Preoperative Patient Characteristics Variable Data (%) Age (y) Male/female 25/20 Emergency procedures 2 (4.4) Previous surgery 3 (6.7) Sinus rhythm 39 (86.7) Concomitant diseases Hypertension 24 (53.3) Coronary heart disease a 14 (31.1) COPD 4 (8.9) Diabetes 4 (8.9) Peripheral vascular disease 5 (11.1) Mitral valve insufficiency 2 (4.4) Functional class NYHA I 5 (11.1) NYHA II 6 (13.3) NYHA III 16 (35.6) NYHA IV 18 (40.0) a Includes 5 patients with insignificant coronary heart disease. COPD chronic obstructive pulmonary disease; NYHA New York Heart Association. Surgical Technique The surgical procedure has been described previously [10, 11]. In brief, the extracorporeal circulation is established by cannulation of the common femoral artery (33 patients) or the aortic arch (22 patients) depending upon the extent of the aneurysm. Myocardial protection is instituted with antegrade cold crystalloid cardioplegia. A modified Bentall technique with complete resection of the ascending aorta and implantation of the coronary ostia in button technique was used in all patients. The composite graft is assembled individually for each patient during surgery using a stentless porcine valve (Toronto SPV; St. Jude Medical Inc, St. Paul, MN) and a collagen-coated woven polyester vascular prosthesis (InterGard; InterVascular, La Ciotat, France). Following the excision of the aortic valve and of the ascending aorta, the aortic annulus is measured. A vascular prosthesis is Table 2. Pathology Pathology Area and Type No. of Patients (%) Aortic valve Insufficiency 23 (51.1) Stenosis 12 (26.7) Mixed 7 (15.6) Previous AVR 2 (4.4) Bicuspid valve 21 (46.7) a Ascending aorta True aneurysm (mean diameter, 58 mm) 42 (93.4) Acute dissection 2 (4.4) Chronic dissection 1 (2.2) a In 1 patient, a severely degenerated bicuspid valve without stenosis or insufficiency was the indication for replacement. AVR aortic valve replacement. selected corresponding to the outer dimension of the annulus and a valve prosthesis of matched size is sewn into the tube graft after measuring the inner diameter of the tube graft with a valve sizer. Because of small Dacron tube manufacturing variances, plus even-numbered labeling diameters for vascular prostheses and oddnumbered sizes of the stentless valves, caliber differences up to 1 mm between the valve and the tube graft must be tolerated. In view of a potential postoperative dilatation of the Dacron graft, we primarily choose a valve prosthesis with a diameter somewhat larger than the tube graft in 29 cases. In the remaining 16 operations, we undersized the valve prosthesis in relation to the Dacron graft. In our study population, tube sizes 30, 28, 26, 24, 22, and 20 were chosen in 2, 25, 13, 2, 2, and 1 patients, respectively. The xenograft is placed inside the tube graft leaving a free margin of the tube of about 3 to 5 mm in length. The proximal suture ring of the valve prosthesis is fixed to the tube graft with a running mattress suture. Doing this, the small difference in circumference between the tube graft and the valve prosthesis has to be divided evenly to avoid tissue buckling or wrinkling (Fig 1). The free margin of the composite graft is then sewn to the aortic annulus with pledgeted interrupted mattress stitches. Following this, the upper circumference of the valve is sutured to the vascular prosthesis with a second running mattress suture. The graft is then fenestrated, and the coronary artery buttons are reimplanted. Finally, the tube graft is anastomosed to the distal aorta. This anastomosis was performed in an open arch technique in 16 patients using hypothermic circulatory arrest because of partial resection of the aortic arch. An additional coronary artery bypass grafting was performed in 10 patients: in 9 patients due to coronary heart disease, and in 1 because of calcification of the right coronary ostium which made its reimplantation impossible. In 1 patient, mitral valve repair, and, in another, mitral valve replacement, was performed. Tissue glue was used only in 1 patient with acute aortic dissection to approximate the dissected wall layers of the distal aorta. Operative data are shown in Table 3. All patients received a transthoracic echocardiogram before discharge. For follow-up, patients and their physicians were contacted. All survivors were asked for an echocardiographic examination, which was performed in 33 patients at our hospital and in 10 patients by a family cardiologist. Written documents and echocardiographic images were requested from physicians and reviewed. Postoperative complications were analyzed according to the Guidelines for Reporting Morbidity and Mortality After Cardiac Valve Operations [12]. Statistical Analysis Values in the tables and text are expressed as mean standard deviation unless otherwise indicated. A Wilcoxon test was used to compare transvalvular gradients between patients receiving composite graft with oversized valve prostheses and those with undersized valve prostheses. Overall survival and freedom from valve-
3 Ann Thorac Surg URBANSKI ET AL 2003;75: VALVED STENTLESS COMPOSITE GRAFT 469 Fig 1. A virtual transversal view of the composite graft from the proximal end. (A) The outer diameter of the valve prosthesis is perfectly adapted to the inner diameter of the Dacron graft. (B) A possible wrinkling of the valve in case of oversizing (arrow). (C) A possible wrinkling of the tube in case of undersizing (arrow). related events were estimated by the Kaplan-Meier method. The statistical analysis was performed with the SPSS software (SPSS Inc, Chicago, IL). Results No patient died in the hospital or within 30 days after surgery. There was one rethoracotomy for bleeding located at the distal graft anastomosis. The mean blood transfusion requirement was units per patient. Two patients had perioperative neurologic events (minor stroke): 1 patient awoke with a cerebrovascular injury, and an embolic event on the 2nd postoperative day was the cause of a neurologic deficit in another patient. Other relevant early complications were pericardial effusion requiring drainage in 3 patients (6.7%), respiratory failure requiring tracheostomy in 1 patient (2.2%), and heart block or bradyarrhythmia requiring permanent pacemaker implantation in 4 patients (8.9%). The mean postoperative hospital stay was days. Patient Survival and Late Morbidity Mean follow-up was months (range, 3 to 30 months) and was complete for all patients. During the Table 3. Operative Data Variable Data (%) Cardiopulmonary bypass duration (min) Aortic cross-clamp time (min) a Circulatory arrest duration (16 patients) (min) Lowest rectal temperature With circulatory arrest ( C) Without circulatory arrest ( C) Concomitant procedures Coronary artery bypass grafting 10 (22.2 %) Mitral valve replacement/repair 2 (4.4 %) a Including duration of circulatory arrest follow-up period, there were two deaths caused by pneumonia and craniocerebral trauma, respectively. Of the 43 survivors, 81.4% (35 patients) were in New York Heart Association (NYHA) functional class I and 18.6% (8 patients) in NYHA II at the time of follow-up. Seventy-eight percent (32 patients) had sinus rhythm compared to 86.7% preoperatively. Seven patients (16.3%) were taking warfarin, and 25 patients (58.1%) were on antiplatelet therapy, usually aspirin. There were three thromboembolic events during the follow-up period, two minor and one major stroke. One event occurred early (2 days) and two events occurred late (3 months and 15 months) after surgery. All 3 of these patients had intermittent or permanent atrial fibrillation in common, and were not on anticoagulants at the time of the event. There were no reports of anticoagulant-related hemorrhage. In 1 patient, prosthetic valve endocarditis was diagnosed 5 months postoperatively. The patient recovered completely after receiving antibiotic therapy and was in NYHA functional class I at the last follow-up. There were no valve-related reoperations. In 1 case, coronary artery bypass grafting was necessary due to a progressive stenosis of the left main coronary artery. Actuarial survival and freedom from any valve-related complications are shown in Figures 2 and 3. Hemodynamic Characteristics The mean gradient of the aortic valve prostheses before hospital discharge was mmhg, and there was no significant difference between the gradients across oversized and undersized valve prostheses ( mmhg versus mmhg; p 0.64). In all cases the valve prostheses were competent without signs of insufficiency. At the time of follow-up, there was a slight but not significant decrease of the mean transvalvular gradient to mmhg, and no aortic incompetence. The valve cusps had no contact with the Dacron tube (Fig 4) and showed no signs of structural deterioration. The outside
4 470 URBANSKI ET AL Ann Thorac Surg VALVED STENTLESS COMPOSITE GRAFT 2003;75: Fig 2. Overall survival after implantation of the valved stentless composite graft. diameter of the Dacron prostheses determined by echoacardiography is 2 mm bigger on average than the inside diameter published by the manufacturer. Bearing in mind the thickness of the tube wall, this means that there is no relevant postoperative dilatation. Comment The similarity of the stentless aortic xenograft and the homograft leads one to expect, in case of a reoperation due to structural valve deterioration, that only the valve cusps and not the entire conduit needs to be resected [13]. The length of these conduits however is limited. In 1998, Westaby described replacement of the aortic root with a stentless xenograft and a Dacron graft extension to replace the ascending aorta [14]. This technique prompts two concerns. The first is that with a xenograft, as with a homograft, calcification may occur not only in the cusps, but also in the aortic wall, which will make reoperation difficult if a complete change of the valve prosthesis becomes necessary. Secondly, the anastomosis between the wall of the xenograft and the Dacron tube can cause bleeding problems, especially when performed under tension. To prevent this complication, other surgeons have proposed a reinforcement of the suture line with a strip of pericardium [15] or a biological adhesive [16]. These steps can reduce the risk of bleeding but do not facilitate reoperation, an option that the surgeon should always bear in mind, when using a biological conduit. In the composite graft described in this article, the stentless valve prosthesis is located within a Dacron tube, thereby protecting the vulnerable tissue of the xenograft from tension forces and limiting the potential late calcification to the valve and not the tube graft. In addition, the supraannular placement of the graft allows implantation of tubes with relatively large caliber (89% of patients received tubes equal or larger than 26 mm). This Fig 3. Freedom from any valve-related complications after implantation of the valved stentless composite graft.
5 Ann Thorac Surg URBANSKI ET AL 2003;75: VALVED STENTLESS COMPOSITE GRAFT 471 Fig 4. M-mode echocardiogram showing the opening of the cusps of the native aortic valve (A) in comparison with a postoperative echocardiogram (B), in which the cusps of the stentless bioprosthesis do not touch the wall of the aortic graft (arrowheads). could facilitate later potential valve re-replacement, because we believe that the feasibility of this valve rereplacement is similar to a valve replacement in a case of valve failure after valve-sparing root reconstruction [17]. The stentless biological valve prosthesis placed in a Dacron tube maintains its favorable hemodynamic characteristics without signs of degenerative changes during the follow-up period of up to 30 months. These results are similar to isolated aortic valve replacement with a Toronto SPV biological prosthesis [18]. Considerations for good and lasting postoperative results include the choice of a Dacron graft that does not dilate. Graft dilatation similar to dilatation of the sinotubular junction in the native aorta could lead to progressive aortic valve insufficiency [19]. When implanting the valve prosthesis into the Dacron tube, care has to be taken to avoid deviation of the commissures and tissue buckling or wrinkling as this could lead to progressive structural degeneration of the valve prosthesis [20, 21]. Correct implantation is simplified by the use of a stentless valve prosthesis and a tube graft with the smallest possible difference in diameter. However, small over- or undersizing of the stentless valve does not seem to have an impact on the hemodynamic outcome. While replacement of the aortic valve and the ascending aorta with a conduit containing a mechanical valve prosthesis has become a standard procedure [22, 23], there is no general agreement on the type of conduit to be used for elderly patients and those with contraindication for lifelong anticoagulation. The composite graft with a stentless biological valve prosthesis, as described, offers an excellent hemodynamic performance and is a suitable device for patients in whom anticoagulation should be avoided. We thank Silvia Martin for preparing the article and Monica Meyer for reviewing the article. References 1. Birkmeyer NJO, Birkmeyer JD, Tosteson ANA, Grunkemeier GL, Marrin CAS, O Connor GT. Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis. Ann Thorac Surg 2000;70: Ehrlich MP, Ergin A, McCullough JN, et al. Favorable outcome after composite valve-graft replacement in patients older than 65 years. Ann Thorac Surg 2001;71: Borst HG, Heinemann MK, Stone CD. Proximal aortic dissection. In: Borst HG, Heinemann MK, Stone SD, eds. Surgical treatment of aortic dissection. New York: Churchill Livingstone, 1996: Dossche KM, Schepens MA, Morshuis WJ, de la Riviere AB, Knaepen PJ, Vermeulen FE. A 23-year experience with composite valve graft replacement of the aortic root. Ann Thorac Surg 1999;67: Westaby S, Huysmans H, David TE. Stentless aortic bioprostheses. Compelling data from the Second International Symposium. Ann Thorac Surg 1998;65: Del Rizzo D, Goldmann BS, Christakis GT, et al. Hemodynamic benefits of the Toronto stentless valve. J Thorac Cardiovasc Surg 1996;112: Jin XY, Gibson DG, Yacoub M, et al. Perioperative assessment of aortic homograft, Toronto stentless valve, and stented bioprosthesis in the aortic position. Ann Thorac Surg 1995; 60:S Melina G, Rubens MB, Amrani M, Khaghani A, Yacoub MH. Electron beam tomography for cusp calcification in homograft versus Freestyle xenografts. Ann Thorac Surg 2001; 71:S Fyfe BE, Schoen FJ. Pathological analysis of non-stented Freestyle aortic root bioprostheses treated with amino-oleic acid. Semin Thorac Cardiovasc Surg 1999;11: Urbanski PP, Hacker RW. Replacement of the aortic valve and ascending aorta with a valved stentless composite graft: technical considerations and early clinical results. Ann Thorac Surg 2000;70: Urbanski PP. Stentless valved composite graft for replacement of the aortic valve and ascending aorta. Med Sci Monit 2001;7: Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller C, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62: Sundt TM III, Rasmi N, Wong K, Radley-Smith R, Khaghani A, Yacoub MH. Reoperative aortic valve operation after homograft root replacement: surgical options and results. Ann Thorac Surg 1995; 60:S Westaby S, Katsumata T, Honel R, Shinfeld A. Stentless xenograft repair of the dissected aortic root. Ann Thorac Surg 1998;65: Akpinar B, Guden M. The use of composite stentless valves with graft extension for the treatment of ascending aortic aneurysms [letter]. Eur J Cardiothoracic Surg 2001;20: Byme JG, Mihaljevic T, Lipson WE, Smith B, Fox JA, Aranki SF. Composite stentless valve with graft extension for combined replacement of the aortic valve, root and ascending aorta. Eur J Cardiothoracic Surg 2001;20: Kamohara K, Itoh T, Natsnaki M, Norita H, Naito K. Early valve failure after aortic valve-sparing root reconstruction. Ann Thorac Surg 1999;68: Goldman BS, David TE, Wood JR, et al. Clinical outcomes after aortic valve replacement with the Toronto stentless porcine valve. Ann Thorac Surg 2001; 71:S David TE, Ivanov J, Eriksson MJ, Bos J, Feindel CM, Rakowski H. Dilatation of the sinotubular junction causes aortic insufficiency after aortic valve replacement with the Toronto SPV bioprosthesis. J Thorac Cardiovasc Surg 2001; 122: Vesely I, Boughner D, Song T. Tissue buckling as a mechanism of bioprosthetic valve failure. Ann Thorac Surg 1988; 46: Nagy ZL, Fisher J, Walker PG, Watterson KG. The effect of sizing on the in vitro hydrodynamic characteristics and leaflet motion of the Toronto SPV stentless valve. J Thorac Cardiovasc Surg 1999;117: Urbanski PP, Wagner M, Zacher M, Hacker RW. Aortic root replacement versus aortic valve replacement: a case-match study. Ann Thorac Surg 2001;72: Svensson LG, Longoria J, Kimmel WA, Nadolny E. Management of aortic valve disease during aortic surgery. Ann Thorac Surg 2000;69:
Composite stentless valve with graft extension for combined replacement of the aortic valve, root and ascending aorta
European Journal of Cardio-thoracic Surgery 20 (2001) 252±256 www.elsevier.com/locate/ejcts Composite stentless valve with graft extension for combined replacement of the aortic valve, root and ascending
More informationReplacement of the Ascending Aorta, Aortic Root and Valve with a Novel Stentless
Title: Replacement of the Ascending Aorta, Aortic Root and Valve with a Novel Stentless Valved-Conduit Running Head: Replacement of Ascending Aorta and Valve Authors: Kelvin K.W. Lau MRCS DPhil Krystyna
More informationThe stentless bioprosthesis has many salient features that
Aortic Valve Replacement with the Medtronic Freestyle Xenograft Using the Subcoronary Implantation Technique D. Michael Deeb, MD The stentless bioprosthesis has many salient features that make it an attractive
More informationEight-Year Results of Aortic Root Replacement With the Freestyle Stentless Porcine Aortic Root Bioprosthesis
Eight-Year Results of Aortic Root Replacement With the Freestyle Stentless Porcine Aortic Root Bioprosthesis Neal D. Kon, MD,* Robert D. Riley, MD, Sandy M. Adair, RN, Dalane W. Kitzman, MD, and A. Robert
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationFemoral Versus Aortic Cannulation for Surgery of Chronic Ascending Aortic Aneurysm
Femoral Versus Aortic Cannulation for Surgery of Chronic Ascending Aortic Aneurysm Fitsum Lakew, MD, Piotr Pasek, MD, Michael Zacher, MD, Anno Diegeler, MD, and Paul P. Urbanski, MD Department of Cardiovascular
More informationReconstruction of the intervalvular fibrous body during aortic and
Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes Nilto C. De Oliveira, MD Tirone E. David, MD Susan Armstrong, MSc Joan Ivanov,
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More informationEleven years experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate
European Journal of Cardio-thoracic Surgery 22 (2002) 912 921 www.elsevier.com/locate/ejcts Eleven years experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with
More informationAnatomy determines the close vicinity of the sinuses of
Aortic Valve Reimplantation According to the David Type I Technique Matthias Karck, MD, and Axel Haverich, MD Department of Thoracic and Cardiovascular Surgery, Hannover Medical School, Hannover, Germany.
More informationResults of Aortic Valve Preservation and Repair
Results of Aortic Valve Preservation and Repair Department of Cardiothoracic and Vascular Surgery Cliniques Universitaires St. Luc Brussels, Belgium Gebrine Elkhoury Institutional experience in AV preservation
More informationCLINICAL COMMUNIQUE 16 YEAR RESULTS
CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced
More informationDepartment of Cardiothoracic Surgery, Heart and Lung Center, Lund University Hospital, Lund, Sweden
Long-Term Outcome of the Mitroflow Pericardial Bioprosthesis in the Elderly after Aortic Valve Replacement Johan Sjögren, Tomas Gudbjartsson, Lars I. Thulin Department of Cardiothoracic Surgery, Heart
More informationThe Ross Procedure: Outcomes at 20 Years
The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationDisease of the aortic valve is frequently associated with
Stentless Aortic Bioprosthesis for Disease of the Aortic Valve, Root and Ascending Aorta John R. Doty, MD, and Donald B. Doty, MD Disease of the aortic valve is frequently associated with morphologic abnormalities
More informationSurgery for Acquired Cardiovascular Disease ACD
Surgery for Acquired Cardiovascular Disease Clinical outcomes after separate and composite replacement of the aortic valve and ascending aorta Thanos Sioris, MD Tirone E. David, MD Joan Ivanov, PhD Susan
More informationAortic valve insufficiency may be caused by abnormalities
Reconstruction of the Ascending Aorta and Aortic Root: Experience in 45 Consecutive Patients Gebrine A. El Khoury, MD, Malcolm J. Underwood, MD, David Glineur, MD, David Derouck, MD, and Robert A. Dion,
More informationIndications and Late Results of Aortic Valve Repair
Indications and Late Results of Aortic Valve Repair Prof. Gebrine El Khoury Department of Cardiovascular and Thoracic Surgery Cliniques St. Luc Brussels, Belgium Aortic Valve Repair Question # 1 Can the
More informationValve-sparing versus composite root replacement procedures in patients with Marfan syndrome
Masters of Cardiothoracic Surgery Valve-sparing versus composite root replacement procedures in patients with Marfan syndrome Joseph S. Coselli 1,2,3, Scott A. Weldon 1,4, Ourania Preventza 1,2,3, Kim
More informationACD. Tirone E. David, MD, Christopher M. Feindel, MD, Susan Armstrong, MSc, and Manjula Maganti, MSc
Replacement of the ascending aorta with reduction of the diameter of the sinotubular junction to treat aortic insufficiency in patients with ascending aortic aneurysm Tirone E. David, MD, Christopher M.
More informationT sors in the following aspects: the porcine aortic valve
Clinical and Hemodynamic Assessment of the Hancock I1 Bioprosthesis Tirone E. David, MD, Susan Armstrong, MSc, and Zhao Sun, MA Division of Cardiovascular Surgery, The Toronto Hospital and University of
More information15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses
ORIGINAL CONTRIBUTION 15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses WR Eric Jamieson, MD, Eva Germann, MSc, Michel R Aupart, MD 1, Paul H Neville, MD 1, Michel A Marchand,
More informationAscending Thoracic Aorta: Postsurgical CT Evaluation
Ascending Thoracic Aorta: Postsurgical CT Evaluation Santiago Martinez Jimenez, MD GOALS Ascending Thoracic Aorta: Postsurgical CT Evaluation Santiago Martínez MD smartinez-jimenez@saint-lukes.org Saint
More informationAortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients
Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients Augusto D Onofrio, MD, Stefano Auriemma, MD, Paolo Magagna, MD, Alessandro Favaro, MD,
More informationCarpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience
SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member
More informationKinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands
Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart
More informationAortic root false aneurysm from gelatin-resorcinolformaldehyde GRF glue following surgical treatment for type A dissection
Jichi Medical University Journal Aortic root false aneurysm from gelatin-resorcinolformaldehyde GRF glue following surgical treatment for type A dissection Yasuhito Sakano, Tsutomu Saito, Yoshio Misawa
More informationClinical material and methods. Copyright by ICR Publishers 2003
Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and
More informationAneurysms of the proximal ascending aorta represent a
Ascending Aortic Replacement With Aortic Valve Reimplantation Wolfgang Harringer, MD; Klaus Pethig, MD; Christian Hagl, MD; Gerd P. Meyer, MD; Axel Haverich, MD Background Reimplantation of the native,
More informationFunctional anatomy of the aortic root. ΔΡΟΣΟΣ ΓΕΩΡΓΙΟΣ Διεσθσνηής Καρδιοθωρακοτειροσργικής Κλινικής Γ.Ν. «Γ. Παπανικολάοσ» Θεζζαλονίκη
Functional anatomy of the aortic root ΔΡΟΣΟΣ ΓΕΩΡΓΙΟΣ Διεσθσνηής Καρδιοθωρακοτειροσργικής Κλινικής Γ.Ν. «Γ. Παπανικολάοσ» Θεζζαλονίκη What is the aortic root? represents the outflow tract from the LV provides
More informationThe operative mortality rate after redo valvular operations
Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationAortic valve repair: Techniques and Pitfalls. Allan Stewart, MD Columbia University Medical Center New York, NY
Aortic valve repair: Techniques and Pitfalls Allan Stewart, MD Columbia University Medical Center New York, NY Take Away Points 1. Valve anatomy is essential to assess repair 2. Unique Decisions with Aneurysm/AI
More informationAn anterior aortoventriculoplasty, known as the Konno-
The Konno-Rastan Procedure for Anterior Aortic Annular Enlargement Mark E. Roeser, MD An anterior aortoventriculoplasty, known as the Konno-Rastan procedure, is a useful tool for the cardiac surgeon. Originally,
More informationHow to Perform a Valve Sparing Root Replacement Joseph S. Coselli, M.D.
How to Perform a Valve Sparing Root Replacement Joseph S. Coselli, M.D. AATS International Cardiovascular Symposium 2017 Session 6: Technical Aspects of Open Surgery on the Aortic Valve Sao Paulo, Brazil
More informationStentless root bioprosthesis for repair of acute type A aortic dissection
ACQUIRED CARDIOVASCULAR DISEASE Stentless root bioprosthesis for repair of acute type A aortic dissection Craig R. Smith, MS, Sotiris C. Stamou, MD, PhD, Robert L. Hooker, MD, Charles C. Willekes, MD,
More informationStentless full root bioprosthesis in surgery for complex aortic valve-ascending aortic disease: a single center experience of over 300 patients
European Journal of Cardio-thoracic Surgery 33 (2008) 554 559 www.elsevier.com/locate/ejcts Stentless full root bioprosthesis in surgery for complex aortic valve-ascending aortic disease: a single center
More informationValve-sparing aortic root replacement in patients with Marfan syndrome the Homburg experience
Masters of Cardiothoracic Surgery Valve-sparing aortic root replacement in patients with Marfan syndrome the Homburg experience Ulrich Schneider, Tristan Ehrlich, Irem Karliova, Christian Giebels, Hans-Joachim
More informationAORTIC VALVE REPLACEMENT WITH FREEHAND AUTOLOGOUS PERICARDIUM
AORTIC VALVE REPLACEMENT WITH FREEHAND AUTOLOGOUS PERICARDIUM Fifty-one patients with a mean age of 31.2 years underwent aortic valve replacement with glutaraldehyde-treated autologous pericardium. Pure
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationTHE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT
THE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT Gideon Cohen, MD Tirone E. David, MD Joan Ivanov, MSc Sue Armstrong, MSc
More informationEarly and Midterm Outcomes of the VSSR procedure with De Paulis valsalva graft: A Chinese single-center Experience in 38 patients
Xu et al. Journal of Cardiothoracic Surgery (2015) 10:167 DOI 10.1186/s13019-015-0347-1 RESEARCH ARTICLE Open Access Early and Midterm Outcomes of the VSSR procedure with De Paulis valsalva graft: A Chinese
More informationAcute type A aortic dissection (Type I, proximal, ascending)
Acute Type A Aortic Dissection R. Morton Bolman, III, MD Acute type A aortic dissection (Type I, proximal, ascending) is a true surgical emergency. It is estimated that patients suffering this calamity
More informationA 20-year experience of 1712 patients with the Biocor porcine bioprosthesis
Acquired Cardiovascular Disease Mykén and Bech-Hansen A 2-year experience of 1712 patients with the Biocor porcine bioprosthesis Pia S. U. Mykén, MD, PhD, a and Odd Bech-Hansen, MD, PhD b Objective: The
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationAortic Valve Resuspension in Ascending Aortic Aneurysm Repair With Aortic Insufficiency
Aortic Valve Resuspension in Ascending Aortic Aneurysm Repair With Aortic Insufficiency Paul Simon, MD, Anton Mortiz, MD, Reinhard Moidl, MD, Natascha Kupilik, MD, Martin Grabenwoeger, MD, Marek Ehrlich,
More informationSURGICAL INTERVENTION IN AORTOPATHIES ZOHAIR ALHALEES, MD RIYADH, SAUDI ARABIA
SURGICAL INTERVENTION IN AORTOPATHIES ZOHAIR ALHALEES, MD RIYADH, SAUDI ARABIA In patients born with CHD, dilatation of the aorta is a frequent feature at presentation and during follow up after surgical
More informationAortic Root Replacement With the Carboseal Composite Graft: 7-Year Experience With the First 100 Implants
Aortic Root Replacement With the Carboseal Composite Graft: 7-Year Experience With the First 100 Implants Giovanni Battista Luciani, MD, Gianluca Casali, MD, Luca Barozzi, MD, and Alessandro Mazzucco,
More informationAnnular Stabilization Techniques in the Context of Aortic Valve Repair
Annular Stabilization Techniques in the Context of Aortic Valve Repair Prashanth Vallabhajosyula, MD MS University of Pennsylvania, Philadelphia, Pennsylvania 2 nd North American Aortic Valve Repair Symposium
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationThe St. Jude Medical Biocor Bioprosthesis
The St. Jude Medical Biocor Bioprosthesis Clinical Evidence of Long-term Durability Long-term Biocor Experience A Review and Comparative Assessment Long-term Biocor Stented Tissue Valve Studies Twenty-year
More informationExperience with 500 Stentless Aortic Valve Replacements
Experience with 500 Stentless Aortic Valve Replacements Dimitrios C. Iliopoulos, MD Cardiac Surgeon Ass. Professor of Surgery University of Athens, School of Medicine I declare no conflict of interest
More informationNineteen-Millimeter Aortic St. Jude Medical Heart Valve Prosthesis: Up to Sixteen Years Follow-up
Nineteen-Millimeter Aortic St. Jude Medical Heart Valve Prosthesis: Up to Sixteen Years Follow-up Dilip Sawant, FRCS, Arun K. Singh, MD, William C. Feng, MD, Arthur A. Bert, MD, and Fred Rotenberg, MD
More informationCoreValve in a Degenerative Surgical Valve
CoreValve in a Degenerative Surgical Valve Ran Kornowski, MD, FESC, FACC Chairman Department of Cardiology Rabin Medical Center, Petach Tikva, Israel Disclosure Statement of Financial Interest I, Ran Kornowski,
More informationThe Bentall procedure: Is it the gold standard? A series of 597 consecutive cases
The Bentall procedure: Is it the gold standard? A series of 597 consecutive cases Christian D. Etz, MD, PhD, Moritz S. Bischoff, MD, Carol Bodian, DrPH, Fabian Roder, MS, Robert Brenner, BS, Randall B.
More informationStentless aortic xenografts were introduced a decade
Survival After Stentless and Stented Xenograft Aortic Valve Replacement: A Concurrent, Controlled Trial Giovanni Battista Luciani, MD, Gianluca Casali, MD, Stefano Auriemma, MD, Francesco Santini, MD,
More informationA Loeys-Dietz Patient with a Trans-Atlantic Odyssey. Repeated Aortic Root Surgery ending with a Huge Left Main Coronary Aneurysm 4
1 2 3 A Loeys-Dietz Patient with a Trans-Atlantic Odyssey Repeated Aortic Root Surgery ending with a Huge Left Main Coronary Aneurysm 4 5 6 7 8 9 Thierry Carrel 1, Florian Schoenhoff 1 and Duke Cameron
More informationControversy exists regarding the extent of proximal
Does the Extent of Proximal or Distal Resection Influence Outcome for Type A Dissections? Marc R. Moon, MD, Thoralf M. Sundt III, MD, Michael K. Pasque, MD, Hendrick B. Barner, MD, Charles B. Huddleston,
More informationAortic stenosis is the most common acquired heart valve. The Toronto Root Bioprosthesis: Midterm Results in 186 Patients
The Toronto Root Bioprosthesis: Midterm Results in 186 Patients Sven Lehmann, MD, Thomas Walther, MD, PhD, Sergey Leontyev, MD, Jörg Kempfert, MD, Jens Garbade, MD, Michael A. Borger, MD, PhD, and Friedrich
More informationAortic valve repair: When and how to employ this novel approach?
Aortic valve repair: When and how to employ this novel approach? Konstadinos A Plestis, MD System Chief of Cardiac Thoracic and Vascular Surgery Main Line Health Care System Professor Sidney Kimmel Medical
More information14 Valvular Stenosis
14 Valvular Stenosis 14-1. Valvular Stenosis unicuspid valve FIGUE 14-1. This photograph shows severe valvular stenosis as it occurs in a newborn. There is a unicuspid, horseshoe-shaped leaflet with a
More information2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD
2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD David L Saint M.D. Tallahassee Memorial Hospital Southern Medical Group Division of Cardiothoracic
More informationAortic root reconstructive surgery - new created technique for aortic stenosis
Aortic root reconstructive surgery - new created technique for aortic stenosis Reconstructive surgery of the aortic root Academician d-r Zan Mitrev, T.Anguseva, E.Stoicovski, E Idoski Special hospital
More informationP have been used for mitral and aortic valve replacement
A -Year Comparison of Mitral Valve Replacement With Carpentier-Edwards and Hancock Porcine Bioprostheses P. Perier, MD, A. Deloche, MD, S. Chauvaud, MD, J. C. Chachques, MD, J. Relland, MD, J. N. Fabiani,
More informationReconstructive surgery of the aortic root
Reconstructive surgery of the aortic root Reconstructive surgery of the aortic root Academician d-r Zan Mitrev MDFETCS Special hospital for surgery Fillip II Skopje - Macedonia february, 2011 Reconstructive
More informationClinical outcomes of aortic root replacement after previous aortic root replacement
Clinical outcomes of aortic root replacement after previous aortic root replacement Luis Garrido-Olivares, MD, MSc, Manjula Maganti, MSc, Susan Armstrong, MSc, and Tirone E. David, MD Objective: The study
More informationEarly and One-year Outcomes of Aortic Root Surgery in Marfan Syndrome Patients
Early and One-year Outcomes of Aortic Root Surgery in Marfan Syndrome Patients A Prospective, Multi-Center, Comparative Study Joseph S. Coselli, Irina V. Volguina, Scott A. LeMaire, Thoralf M. Sundt, Elizabeth
More informationRepair of the aortic valve in patients with insufficiency and aortic root aneurysm
Surgery for Acquired Heart Disease Repair of the aortic valve in patients with insufficiency and aortic root aneurysm aortic Patients with aneurysms of the ascending aorta or aortic root frequently have
More informationSurgical Procedures and Complications
Radiological Society of North America, RSNA 2013 Refresher Course Program: Vascular Track Surgical Procedures and Complications Learning objectives Outline RC 112 : Key Concepts: Surgical Procedures and
More informationDurability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement
Durability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement Masaki Hamamoto, MD, Ko Bando, MD, Junjiro Kobayashi, MD, Toshihiko Satoh, MD, MPH, Yoshikado
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationAORTIC ROOT RECONSTRUCTION WITH PRESERVATION OF NATIVE AORTIC VALVE AND SINUSES IN AORTIC ROOT DILATATION WITH AORTIC REGURGITATION
AORTIC ROOT RECONSTRUCTION WITH PRESERVATION OF NATIVE AORTIC VALVE AND SINUSES IN AORTIC ROOT DILATATION WITH AORTIC REGURGITATION Jacques A. M. van Son, MD, PhD Roberto Battellini, MD Marco Mierzwa,
More information42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim
42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of
More informationOperative Strategy. Operative Technique
Domingo Liotta, M.D.; Christian Cabrol, M.D; Miguel del Rio, M.D; Armando Diluch, M.D; Adriano Malusardi, M.D. Figure 11 Acute dissected aortic root and ascending aorta with valvular regurgitation. -Replacement
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More informationCase. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP)
Case 15-year-old boy with bicuspid AV Severe AR with moderate AS Ross vs. AVR (or AVP) AMC case 14-year-old boy with bicuspid AV Severe AS with mild AR Body size Bwt: 55 kg, Ht: 154 cm, BSA: 1.53 m 2 Echocardiography
More informationTranscatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital,
Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital, Oslo, Norway Aortic regurgitation Prevalence in Framingham
More informationInterventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504
Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This
More informationHani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.
Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility
More informationThe Edge-to-Edge Technique f For Barlow's Disease
The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele
More informationThe Role Of Decellularized Valve Prostheses In The Young Patient
The Role Of Decellularized Valve Prostheses In The Young Patient Francisco Diniz Affonso da Costa Human Tissue Bank PUCPR - Brazil Disclosures Ownership and patent license of the SDS decellularization
More informationThe life expectancy of patients with Marfan syndrome has increased
Karck et al Surgery for Acquired Cardiovascular Disease Aortic root surgery in Marfan syndrome: Comparison of aortic valve-sparing reimplantation versus composite grafting Matthias Karck, MD Klaus Kallenbach,
More informationLate failure of transcatheter heart valves: An open question
Late failure of transcatheter heart valves: An open question A comparison with surgically implanted bioprosthetic heart valves. A. Rashid The Cardiothoracic Centre Liverpool, UK. Conflict of Interest Statement
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationProf. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation
Prof. Dr. Thomas Walther TAVI in ascending aorta / aortic root dilatation nn AorticStenosis - Guidelines TAVI and aortic aneurysm? Few data published. EJCTS 2014;46:228-33 TAVI and aortic aneurysm? Few
More informationDecellularization of Aortic Homografts: South American and European Current Experience
Department of Cardiac Surgery Instituto de Neurologia e Cardiologia de Curitiba (INC-Cardio) Decellularization of Aortic Homografts: South American and European Current Experience Francisco Diniz Affonso
More informationThe vast majority of patients, especially children, who
Technique of Mechanical Pulmonary Valve Replacement John M. Stulak, MD, and Joseph A. Dearani, MD The vast majority of patients, especially children, who require pulmonary valve replacement (PVR), obtain
More informationMarfan s S drome: Combined Composite Valve GrAeplacement of the Aortic Root and Transaortic Mihal Valve Replacement
Marfan s S drome: Combined Composite Valve GrAeplacement of the Aortic Root and Transaortic Mihal Valve Replacement E. Stanley Crawford, M.D., and Joseph S. Coselli, M.D. ABSTRACT Echocardiographic studies
More informationHemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves
Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Speaker's name: I have the following potential conflicts of interest to report: Proctorship for Medtronic Agenda Failure modes
More informationRe-do aortic valve replacement after previous homograft aortic root replacement
Re-do aortic valve replacement after previous homograft aortic root replacement Jullien Gaer, Toufan Bahrami, Fabio de Robertis, Ahmed Abdulsalam, John Pepper, NHS Foundation Trust, UK Professor Sir Magdi
More informationReplacement of the mitral valve in the presence of
Mitral Valve Replacement in Patients with Mitral Annulus Abscess Christopher M. Feindel Replacement of the mitral valve in the presence of an abscess of the mitral annulus presents a major challenge to
More informationThe need for right ventricular outflow tract reconstruction
Polytetrafluoroethylene Bicuspid Pulmonary Valve Implantation James A. Quintessenza, MD The need for right ventricular outflow tract reconstruction and pulmonary valve replacement is increasing for many
More informationFocused. se with 2008 F. lar Heart Diseas. date. ents With Valvul. Upd. gement of Patie. lines for Manag. HA 2006 Guidel ACC/AH. Fig.
ACC/AH HA 2006 Guidel nic severe AI (Fig. 4). ned by age, ay also be helpful nd echo. For AI, ollow up may be or MRI rather than mension; SD, end lines for Manag gement of Patie Upd ents With Valvul date
More informationNew Technique for Aortic Valve Functional Annulus Reshaping Using a Handmade Prosthetic Ring
New Technique for Aortic Valve Functional Annulus Reshaping Using a Handmade Prosthetic Ring Khalil Fattouch, MD, PhD, Roberta Sampognaro, MD, Giuseppe Speziale, MD, and Giovanni Ruvolo, MD Department
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationThe Rastelli procedure has been traditionally used for repair
En-bloc Rotation of the Truncus Arteriosus A Technique for Complete Anatomic Repair of Transposition of the Great Arteries/Ventricular Septal Defect/Left Ventricular Outflow Tract Obstruction or Double
More information